Search This Blog

Thursday, February 6, 2020

Ligand Pharmaceuticals beats on revenue

Ligand Pharmaceuticals (NASDAQ:LGND): Q4 Non-GAAP EPS of $0.71; GAAP EPS of -$0.43.
Revenue of $27M (-54.7% Y/Y) beats by $1.83M.
Press Release
https://seekingalpha.com/news/3539406-ligand-pharmaceuticals-beats-on-revenue
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)